^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Non-Hodgkin’s Lymphoma |
| Drug: | cisplatin (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
01/05/2023
Excerpt:
Extranodal NK/T-Cell Lymphomas...INDUCTION THERAPY….Other recommended regimens….CCRT: RT and cisplatin followed by VIPD (etoposide, ifosfamide, cisplatin, and dexamethasone) x 3 cycles.
Secondary therapy:
VIPD
